Vivos Therapeutics has entered a collaboration with South Palm Cardiovascular Associates to form AIM Florida, aiming to improve diagnosis and treatment of sleep apnea and insomnia in cardiovascular patients. This partnership leverages Vivos' technology and SPCVA's cardiology expertise to address the high risk of cardiovascular events linked to untreated sleep disorders. The initiative will start in Palm Beach County and plans to scale across Florida and potentially nationwide, enhancing patient care and driving Vivos' growth. The collaboration expects to generate significant revenue while maintaining compliance with healthcare regulations.
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
Alibaba and Baidu shares rose after Apple received approval from China's Cyberspace Administration to include Apple Intelligence, integrating Alibaba's Qwen AI model and Baidu's AI features into Apple devices in China. This partnership allows users t...
